KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gilead Sciences (GILD) Interest Expenses (2016 - 2025)

Gilead Sciences (GILD) has disclosed Interest Expenses for 17 consecutive years, with $255.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Interest Expenses rose 2.41% year-over-year to $255.0 million, compared with a TTM value of $1.0 billion through Dec 2025, up 4.7%, and an annual FY2025 reading of $1.0 billion, up 4.81% over the prior year.
  • Interest Expenses was $255.0 million for Q4 2025 at Gilead Sciences, roughly flat from $256.0 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $260.0 million in Q1 2025 and bottomed at $226.0 million in Q4 2022.
  • Average Interest Expenses over 5 years is $244.1 million, with a median of $245.5 million recorded in 2022.
  • The sharpest move saw Interest Expenses fell 10.86% in 2021, then grew 11.5% in 2023.
  • Year by year, Interest Expenses stood at $238.0 million in 2021, then dropped by 5.04% to $226.0 million in 2022, then increased by 11.5% to $252.0 million in 2023, then decreased by 1.19% to $249.0 million in 2024, then grew by 2.41% to $255.0 million in 2025.
  • Business Quant data shows Interest Expenses for GILD at $255.0 million in Q4 2025, $256.0 million in Q3 2025, and $253.0 million in Q2 2025.